Atticus Capital Boosts Stake in Inverness Medical (IMA) to 5.5%
In a 13G filing this afternoon on Inverness Medical Innovations Inc. (AMEX: IMA), Atticus Capital LP disclosed a 5.45% stake (2,537,806 shares) in the company. This is up from the 1,519,400 share stake the firm held at the quarter ended March 31, 2007.
While the 13G indicates a passive stance, Atticus Capital is known as an activist investor.
Inverness recently won a bidding war for Biosite (Nasdaq: BSTE).
While the 13G indicates a passive stance, Atticus Capital is known as an activist investor.
Inverness recently won a bidding war for Biosite (Nasdaq: BSTE).
You May Also Be Interested In
- Sirios Capital Raises Stake in Clearwire (CLWR) to 6.66%
- Mandel's Lone Pine Capital Raises Stake in Ulta Salon (ULTA) to 5.6%
Create E-mail Alert Related Categories
13GsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
